<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000984.v1.p1" parentStudy="phs000984.v1.p1" createDate="2015-09-01" modDate="2016-09-21">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator (NUgene)</td><td>Rex Chisholm, PhD</td><td>Northwestern University</td></tr>
		<tr><td>Funding Source</td><td>UL1TR0001501</td><td>National Human Genome Research Institute (NHGRI), National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Pharmacogenomics of Metformin Dose Response in T2DM Patients</StudyNameEntrez>
	<StudyNameReportPage>Pharmacogenomics of Metformin Dose Response in T2DM Patients</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case Set</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Type 2 Diabetes Mellitus (T2DM) is a chronic and sometimes debilitating disease that affects millions of adults in the USA. Metformin is commonly prescribed for T2DM; yet some T2DM patients do not tolerate it or respond well. This pharmacogenomics study will examine response, as both change in T2DM patients&#39; weight and hemoglobin A1c (HbA1c) levels, to different doses of metformin, by extracting this data from the electronic health record (EHR), for T2DM subjects taking metformin found by prescription orders in the EHR, and identified as cases with the EHR phenotype algorithm published by Kho et. al. in 2012 (PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/22101970" target="_blank">22101970</a> as part of the eMERGE (electronic Medical Records and Genomics; dbGaP <a href="./study.cgi?study_id=phs000237">phs000237</a>, <a href="./study.cgi?study_id=phs000297">phs000297</a>, <a href="./study.cgi?study_id=phs000360">phs000360</a>, <a href="./study.cgi?study_id=phs000368">phs000368</a>, <a href="./study.cgi?study_id=phs000888">phs000888</a>, and <a href="./study.cgi?study_id=phs000948">phs000948</a>) project.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Subjects were determined using an electronic algorithm for type 2 diabetes mellitus deployed with an existing EMR that was previously published by Kho AN, Hayes MG, Rasmussen-Torvik L, et al. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc. 2012 Mar-Apr;19(2):212-8. Epub 2011 Nov 19. PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/22101970" target="_blank">22101970</a>.</p> <p>Additional inclusion criteria included having been prescribed metformin.</p> <p>There were no additional exclusion criteria.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="22101970"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Diabetes Mellitus, Type 2"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator (NUgene)">
			<AttName>Rex Chisholm, PhD</AttName>
			<Institution>Northwestern University</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>UL1TR0001501</AttName>
			<Institution>National Human Genome Research Institute (NHGRI), National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="0" shortName="NRUP" longName="Subjects did not participate in the study, did not complete a consent document and are included only for the pedigree structure and/or genotype controls, such as HapMap subjects"/>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIGMS</DacName>
      <DacFullName>National Institute of General Medical Sciences DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000984.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>6</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000984.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000984.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.
May be used for genetic studies to learn about, prevent, or treat health problems. 
No Insurance companies may be allowed to use this data.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
